Similar Items: Evaluation of Treatment Outcomes of Patients with Chronic Phase Chronic Myelogenous Leukemia (CML) to Imatinib: A Single Centre Experience 2010-2015 Period
- Genetic Analysis of Imatinib Resistance in CML: The Role of T315I and E255K
- Imatinib resistance : the role of pharmacogenetic variability in a South African chronic myeloid leukemia cohort
- Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia
- Blood Pressure Alterations in CML Patients Treated with Imatinib vs. Nilotinib : A Clinical Insight
- Clinical Evaluation of Immediate Implantation in Molars with Chronic Apical Periodontitis and Chronic Periodontitis
- Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives